ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: BCR-ABL TKIs have thus transformed CML from a highly lethal disease treated with chemotherapy and allogeneic stem cell transplantation into a chronic illness with excellent long-term survival.